Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
407.2 USD | +8.21% | +5.74% | +32.83% |
Apr. 23 | Transcript : Medpace Holdings, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 23 | Jefferies Upgrades Medpace Holdings to Buy, Price Target at $450 | MT |
Financials (USD)
Sales 2024 * | 2.18B | Sales 2025 * | 2.53B | Capitalization | 12.59B |
---|---|---|---|---|---|
Net income 2024 * | 353M | Net income 2025 * | 414M | EV / Sales 2024 * | 5.44 x |
Net cash position 2024 * | 739M | Net cash position 2025 * | 1.08B | EV / Sales 2025 * | 4.54 x |
P/E ratio 2024 * |
37
x | P/E ratio 2025 * |
31.5
x | Employees | 5,900 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 81.65% |
Latest transcript on Medpace Holdings, Inc.
1 day | +8.21% | ||
1 week | +5.74% | ||
Current month | +0.74% | ||
1 month | -0.40% | ||
3 months | +36.17% | ||
6 months | +78.95% | ||
Current year | +32.83% |
Managers | Title | Age | Since |
---|---|---|---|
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Kevin Brady
DFI | Director of Finance/CFO | 49 | 18-10-31 |
Jesse Geiger
PSD | President | 49 | 07-09-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Fred Davenport
BRD | Director/Board Member | 72 | 18-08-12 |
August Troendle
CEO | Chief Executive Officer | 67 | 92-06-30 |
Director/Board Member | 64 | 18-08-12 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
1.15% | 2 M€ | -.--% | ||
0.49% | 0 M€ | 0.00% | - | |
0.40% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-23 | 407.2 | +8.21% | 808,514 |
24-04-22 | 376.3 | +1.15% | 357,745 |
24-04-19 | 372 | -0.62% | 221,668 |
24-04-18 | 374.3 | -2.12% | 219,892 |
24-04-17 | 382.4 | -0.68% | 212,271 |
Delayed Quote Nasdaq, April 23, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+32.83% | 12.59B | |
+3.13% | 43.43B | |
+48.60% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+6.63% | 11.03B | |
-17.46% | 10.01B |
- Stock Market
- Equities
- MEDP Stock